These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 8467284

  • 1. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
    Carlson K, Smedmyr B, Hagberg H, Oberg G, Simonsson B.
    Bone Marrow Transplant; 1993 Mar; 11(3):205-8. PubMed ID: 8467284
    [Abstract] [Full Text] [Related]

  • 2. Renal function after autologous bone marrow transplantation.
    Lönnerholm G, Carlson K, Bratteby LE, Bäcklund L, Hagberg H, Rikner G, Smedmyr B, Oberg G, Simonsson B.
    Bone Marrow Transplant; 1991 Aug; 8(2):129-34. PubMed ID: 1933054
    [Abstract] [Full Text] [Related]

  • 3. Hemolytic uremic syndrome after autologous BMT without TBI.
    Raybon KB, Snyder MJ, Halvorson RD.
    Bone Marrow Transplant; 1996 May; 17(5):897-8. PubMed ID: 8733719
    [No Abstract] [Full Text] [Related]

  • 4. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
    Snyder MJ, Johnson DB, Daly MB, Giguere JK, Harman GH, Harden EA, Johnson RA, Leff RS, Mercier RJ, Messerschmidt GL.
    Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534
    [Abstract] [Full Text] [Related]

  • 5. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [Abstract] [Full Text] [Related]

  • 6. BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.
    Jo JC, Kang BW, Jang G, Sym SJ, Lee SS, Koo JE, Kim JW, Kim S, Huh J, Suh C.
    Ann Hematol; 2008 Jan; 87(1):43-8. PubMed ID: 17710401
    [Abstract] [Full Text] [Related]

  • 7. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
    Weaver CH, Schwartzberg L, Li W, Hazelton B, West W.
    Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.
    Decaudin D, Brousse N, Brice P, Haioun C, Bourhis JH, Morel P, Van Hoof A, Souleau B, Quesnel B, Gisselbrecht C.
    Bone Marrow Transplant; 2000 Feb; 25(3):251-6. PubMed ID: 10673695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma.
    Weaver CH, Schwartzberg L, Rhinehart S, West J, Zhen B, West WH, Buckner CD.
    Bone Marrow Transplant; 1998 Feb; 21(4):383-9. PubMed ID: 9509973
    [Abstract] [Full Text] [Related]

  • 13. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
    Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR.
    Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790
    [Abstract] [Full Text] [Related]

  • 14. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA.
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [Abstract] [Full Text] [Related]

  • 15. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N, August CS, Bunin N, Leahey A, Bayever E, Goldwein J, Zusman J, Evans AE, Angio GD.
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [Abstract] [Full Text] [Related]

  • 16. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P.
    Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
    [Abstract] [Full Text] [Related]

  • 17. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R, Sancho G, Bieri S, Carrió I, Helg C, Brunet S, Martin PY, Sureda A, Gomez De Segura G, Chapuis B, Estorch M, Ozsahin M, Keller A.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):809-16. PubMed ID: 14967438
    [Abstract] [Full Text] [Related]

  • 18. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E.
    Bone Marrow Transplant; 2004 Oct 01; 34(7):581-7. PubMed ID: 15273714
    [Abstract] [Full Text] [Related]

  • 19. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?
    Chappell ME, Keeling DM, Prentice HG, Sweny P.
    Bone Marrow Transplant; 1988 Jul 01; 3(4):339-47. PubMed ID: 2844348
    [Abstract] [Full Text] [Related]

  • 20. ABMT for early isolated extramedullary relapse of childhood ALL.
    Rossetti F, Messina C, Miniero R, Busca A, Sotti G, Cesaro S, Zanesco L, Colleselli P, Scotti G [corrected to Sotti G].
    Bone Marrow Transplant; 1993 Jul 01; 12(1):37-41. PubMed ID: 8374535
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.